ARCHIVES

DeVita Considers Alternatives to Recommendation Of NCAB On Organ Systems Coordinating Center

This article is from The Cancer Letter archive.

Vol. 10 No. 22 | June 1, 1984

Download PDF Visit The Full Archive

Related Articles

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

August 7, 2009

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

Guest Editorial by Robert Cook-Deegan: Myriad Case Ruling Likely to Concur With DOJ Arguments

April 19, 2013

Other ASCO Plenary Papers: Long Awaited Chemotherapy Results

June 12, 1992

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

January 31, 2014

White House Yet To Name NCAB, Cancer Panel Members

February 11, 2011